Abdominal pain after eating usually gets blamed on acid, the gallbladder or nerves. Sometimes the trouble sits behind the gut wall, in arteries that cannot open wide enough to meet a meal, and no amount of looking at the lining will find it.
In the video above, titled Your Gut Is Suffocating, I walk through an argument from The Angry Gut, written by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Below is what a pain patient needs beyond the video: why this pain gets missed, why the tests are weaker than they sound, and why the drugs that tinker with nitric oxide teach caution.
Why pain after a meal can be a blood flow problem
Digestion is a circulatory demand. Blood flow to the bowel rises by up to 30-150% after eating (Terlouw et al., 2020). An artery that copes at rest can fall short at the table, and narrowing of the gut arteries is common: in autopsy and ultrasound series, significant stenosis shows up in 6-29%, rising possibly to 67% after age 80.
A mildly narrowed artery does not kill bowel. It produces pain on a schedule. The meal arrives, demand rises, supply stalls, and the gut hurts. People learn quickly. They eat smaller meals, eat later, then skip meals entirely, and the avoidance gets read as a mood problem or an eating problem rather than a circulation problem.
One patient of mine was seventy-three. He had stopped eating lunch about a year earlier because pain came twenty minutes after food. He had atrial fibrillation and high blood pressure and a normal body weight. He had four scopes, and nobody had imaged an artery. The European guideline now names the expectation of a wasted, starving patient as a diagnostic pitfall, because it delays the diagnosis in people who look like him.
The villus tip is the first place to run short
Your gut is the first brain, and it is fed from behind. The tiny fronds that absorb food, the villi, receive blood through an arteriole that runs up beside a venule, and oxygen leaks across before it reaches the top. The tip lives at the end of the supply line.
Clamp a segment of human small bowel for thirty minutes and an enterocyte damage marker climbs from 290 pg/ml to 3,997 pg/ml. Gaps opened first at the villus tips. The injured cells were shed during reperfusion, and the barrier resealed within 60 minutes (Derikx et al., 2008). The lining repairs quickly when blood comes back. It cannot repair while blood stays short.
You do not need surgery to see the effect. Healthy young men exercising hard divert blood away from the bowel, and their damage marker roughly doubled, 615 ± 118 against 309 ± 46 pg/ml (van Wijck et al., 2011). A gut that is never infarcted but never quite fed is a gut that stays sore, slow to heal, and reactive to every meal. That is a delivery problem, not a wound problem.
Why four normal scopes did not rule it out
A scope looks at the inner surface. The shortfall is in the supply behind it, so a normal scope answers a different question. Imaging the mesenteric arteries is where the vascular workup starts.
Measuring the oxygen that actually reaches the lining is harder than it sounds. A light probe passed through the scope reads tissue saturation, and in one study it ran 67 ± 9% in chronic mesenteric ischemia against 81 ± 4% in controls. At a cutoff of 78% it caught 94% of cases but mislabeled about one control in four, with specificity of 72%, and the cutoff was drawn in the same group it was tested on (Berge et al., 2019). Later work found two operators disagreed often enough to flip the answer. The honest position is that this injury is easy to cause and hard to see.
For pain patients this matters in a specific way. A normal test is often treated as permission to stop looking, and a person who has stopped eating to avoid pain gets filed under anxiety. If meals reliably hurt and food intake or weight is falling, ask whether anyone has looked at the arteries.
Nitric oxide: the molecule that opens vessels and the one that inflames them
The endothelium, the lining of your vessels, makes nitric oxide continuously to keep small arteries open. When its raw materials run short, the enzyme uncouples and makes superoxide instead, a driver of endothelial dysfunction (Janaszak-Jasiecka et al., 2021). The enzyme built to open your vessels starts corroding them.
A different enzyme floods inflamed tissue. Rectal nitric oxide sat at a median of 45 parts per billion in healthy people and 3475 ppb in active inflammatory bowel disease. Irritable bowel syndrome sat at 150 ppb, close to healthy (Reinders et al., 2005). For anyone living with gut pain, that split is useful: the painful bowel of irritable bowel syndrome is not running the same inflammatory fire.
Medicine has tried to adjust this molecule directly, and pain patients meet the results. Topical glyceryl trinitrate, a nitric oxide donor, heals anal fissures better than placebo at a relative risk of 1.96, and causes headache at a relative risk of 2.73, with the harm graded more certain than the benefit (Jin et al., 2021). Bolting a nitric oxide donor onto naproxen changed what the painkiller did to blood pressure: plain naproxen raised systolic pressure 1.4 mmHg against placebo, while the donating version moved it by minus 0.4 (White et al., 2011). That drug never reached the American market. The lesson is not that more nitric oxide fixes the gut. It is that the working endothelium is the target, and the cardiovascular cost of common painkillers belongs in the same conversation.
One endothelium, three specialists
The man with lunch pain had also reported erectile dysfunction to a different doctor, who wrote a prescription and asked nothing else. An erection is a nitric oxide event in a small artery, so it fails early. Across 14 studies and 92,757 participants, erectile dysfunction predicted cardiovascular events at 1.44 and heart attack at 1.62 (Vlachopoulos et al., 2013). In men with coronary disease who had both, the sexual symptom came first in 93%, by a mean of 24 months (Montorsi et al., 2006).
The system is organized against seeing this. Erections go to urology, lunch pain to gastroenterology, blood pressure to cardiology, and each visit closes around its own organ. I was trained the same way. Three silos, one vessel lining, and a patient left to connect them himself.
This is the same logic we apply to microvascular dysfunction as a hidden cause of chronic pain: the small vessels fail before any scan shows it, and the symptom shows up in whatever tissue has the least reserve.
What changed for him, and what it means for you
The humbling part is that the first brain cannot be rescued from inside the first brain. We imaged his mesenteric arteries. We replaced the antiseptic mouthwash he had used twice a day since 2009, because the bacteria it kills convert dietary nitrate into a backup supply of nitric oxide. He started eating green leafy vegetables daily for that nitrate, and his household stopped reusing frying oil, since oxidized fat damages the same enzyme.
None of those is a treatment on its own. Each sits upstream of the same molecule, and he had been losing it several ways at once. The evidence tier is mechanistic for the combination; no trial has enrolled a patient like him and tested all of it together. The two biological drivers are a failing endothelium and a lost bacterial backup. The third driver is a care system that splits one vascular problem across three offices.
Your part is concrete. Tell every physician about every symptom, including the embarrassing one. If meals hurt, ask about the arteries. Do not change any medication on your own; work it through with the physician who prescribed it. The Chapter 9 Deep Dive lays out every study behind this, with full numbers and what each does and does not show. The membranes these vessels feed are built from diet, as fish oil, seed oils and the gut wall explains, and vitamin D as a hormone follows the immune cells that blood delivers.
Frequently asked questions
What causes abdominal pain after eating?
Most causes live in the gut itself, including acid, gallbladder disease and irritable bowel syndrome. A less recognized cause is reduced blood flow: digestion raises the gut’s blood demand sharply, and a narrowed artery that copes at rest can fall short after a meal. Pain that arrives reliably after food, with eating less over time, deserves a look at the arteries. How upper abdominal pain is traced to its pathway covers another route.
What are the symptoms of chronic mesenteric ischemia?
The classic pattern is pain after meals, often worse after large ones, that leads people to eat less or skip meals. The European guideline warns that expecting a thin, wasted patient is a diagnostic pitfall, because many people with the condition have a normal weight. Normal scopes do not exclude it, since the problem is in the arteries. Why pain is a signal and not a diagnosis explains the broader principle.
Is erectile dysfunction an early sign of heart disease?
It often is. Across 14 studies and 92,757 participants, erectile dysfunction predicted cardiovascular events and heart attack, and in men with coronary disease who had both, the sexual symptom usually came first, by about two years. It reflects small-artery nitric oxide function, which is why it deserves a cardiovascular question rather than only a prescription. How high insulin damages the terrain behind pain connects the metabolic side.
Can hard exercise reduce blood flow to the gut?
Yes. In healthy young men, strenuous exercise diverted blood from the bowel and roughly doubled a marker of gut lining damage. In healthy people the lining repairs quickly once flow returns, so this is not a reason to stop exercising. It shows how sensitive the villus tip is to supply. Why muscle is your own anti-inflammatory medicine covers what exercise gives back.
Is high nitric oxide in the gut a sign of inflammation?
In the lumen, yes. Rectal nitric oxide runs about a hundred times higher in active inflammatory bowel disease than in healthy people, driven by an inflammatory enzyme, while irritable bowel syndrome sits near normal. That is different from the steady nitric oxide your vessel lining makes to stay open, which is the kind worth protecting. Why we treat insulin before we treat the joint shows the terrain-first approach.
Pain after meals deserves more than another scope
When eating hurts and the workup keeps coming back normal, we look behind the gut wall at the blood supply and the metabolic terrain that feeds it.
Request an appointment, call (314) 481-5000, or text (314) 886-5902.
Sources
- Terlouw, L. G., Moelker, A., Abrahamsen, J., Acosta, S., Bakker, O. J., Baumgartner, I., Boyer, L., Corcos, O., van Dijk, L. J., Duran, M., Geelkerken, R. H., Illuminati, G., Jackson, R. W., Kärkkäinen, J. M., Kolkman, J. J., Lönn, L., Mazzei, M. A., Nuzzo, A., Pecoraro, F., … Bruno, M. J. (2020). European guidelines on chronic mesenteric ischaemia – joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepatogastroenterologists, Hellenic Society of Gastroenterology, Cardiovascular and Interventional Radiological Society of Europe, and Dutch Mesenteric Ischemia Study group clinical guidelines on the diagnosis and treatment of patients with chronic mesenteric ischaemia. United European Gastroenterology Journal, 8(4), 371-395. https://doi.org/10.1177/2050640620916681
- Derikx, J. P. M., Matthijsen, R. A., de Bruïne, A. P., van Bijnen, A. A., Heineman, E., van Dam, R. M., Dejong, C. H. C., & Buurman, W. A. (2008). Rapid reversal of human intestinal ischemia-reperfusion induced damage by shedding of injured enterocytes and reepithelialisation. PLoS ONE, 3(10), e3428. https://doi.org/10.1371/journal.pone.0003428
- van Wijck, K., Lenaerts, K., van Loon, L. J., Peters, W. H., Buurman, W. A., & Dejong, C. H. (2011). Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men. PLoS ONE, 6(7), e22366. https://doi.org/10.1371/journal.pone.0022366
- Berge, S. T., Safi, N., Medhus, A. W., Ånonsen, K., Sundhagen, J. O., Hisdal, J., & Kazmi, S. S. H. (2019). Gastroscopy assisted laser Doppler flowmetry and visible light spectroscopy in patients with chronic mesenteric ischemia. Scandinavian Journal of Clinical and Laboratory Investigation, 79(7), 541-549. https://doi.org/10.1080/00365513.2019.1672084
- Janaszak-Jasiecka, A., Siekierzycka, A., Płoska, A., Dobrucki, I. T., & Kalinowski, L. (2021). Endothelial dysfunction driven by hypoxia—The influence of oxygen deficiency on NO bioavailability. Biomolecules, 11(7), 982. https://doi.org/10.3390/biom11070982
- Reinders, C. I., Herulf, M., Ljung, T., Hollenberg, J., Weitzberg, E., Lundberg, J. O., & Hellström, P. M. (2005). Rectal mucosal nitric oxide in differentiation of inflammatory bowel disease and irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 3(8), 777-783. https://doi.org/10.1016/s1542-3565(05)00182-5
- Jin, J. Z., Hardy, M. O., Unasa, H., Mauiliu-Wallis, M., Weston, M., Connolly, A., Singh, P. P., & Hill, A. G. (2021). A systematic review and meta-analysis of the efficacy of topical sphincterotomy treatments for anal fissure. International Journal of Colorectal Disease, 37(1), 1-15. https://doi.org/10.1007/s00384-021-04040-3
- White, W. B., Schnitzer, T. J., Bakris, G. L., Frayssinet, H., Duquesroix, B., & Weber, M. (2011). Effects of naproxcinod on blood pressure in patients with osteoarthritis. The American Journal of Cardiology, 107(9), 1338-1345. https://doi.org/10.1016/j.amjcard.2010.12.046
- Vlachopoulos, C. V., Terentes-Printzios, D. G., Ioakeimidis, N. K., Aznaouridis, K. A., & Stefanadis, C. I. (2013). Prediction of cardiovascular events and all-cause mortality with erectile dysfunction: A systematic review and meta-analysis of cohort studies. Circulation: Cardiovascular Quality and Outcomes, 6(1), 99-109. https://doi.org/10.1161/CIRCOUTCOMES.112.966903
- Montorsi, P., Ravagnani, P. M., Galli, S., Rotatori, F., Veglia, F., Briganti, A., Salonia, A., Dehò, F., Rigatti, P., Montorsi, F., & Fiorentini, C. (2006). Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: The COBRA trial. European Heart Journal, 27(22), 2632-2639. https://doi.org/10.1093/eurheartj/ehl142
Dr. Gurpreet Singh Padda, MD, MBA, MHP


